Biomarkers, Diagnostics and Precision Medicine in the Drug Industry by Halim, Abdel;

Critical Challenges, Limitations and Roadmaps for the Best Practices

10% KEDVEZMÉNY?
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.

Kiadói listaár EUR 132.00
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.

54 747 Ft (52 140 Ft + 5% áfa)
Kedvezmény(ek) 10% (cc. 5 475 Ft off)
Kedvezményes ár 49 272 Ft (46 926 Ft + 5% áfa)

54 747 Ft

Beszerezhetőség

Megrendelésre a kiadó utánnyomja a könyvet. Rendelhető, de a szokásosnál kicsit lassabban érkezik meg.

A termék adatai:

Kiadó Elsevier Science
Megjelenés dátuma 2019. június 11.

ISBN 9780128161210
Kötéstípus Puhakötés
Terjedelem294 oldal
Méret 276x215 mm
Súly 750 g
Nyelv angol

Kategóriák

Farmakológia, terapeutika, toxikológia Gyógyszerészet

Hosszú leírás:

The high failure rate in the pharmaceutical industry has positioned biomarkers and personalized medicine in the frontline, as possible solutions. If executed right, biomarkers and companion diagnostics (CDx) can potentially help the drug industry enhance the probability of success, accelerate the time to market, and, more importantly, benefit patients by supporting accurate diagnosis and selection of the most effective and least toxic therapies. This book aims to examine the challenges and limitations in biomarkers and laboratory tests. It also offers advice on best practices to ensure proper application of biomarkers and bridges the gap between diagnostic business development claims and real-life deliverables. The book covers biomarkers for different purposes, provides examples from different technologies, which includes standard-of-care approved assays as well as for-investigational-use and for-research-use-only assays. It also includes new data for biomarkers in different therapeutic indications and offers case studies and practical examples.

This book serves as a reference to drug developers, IVD providers, clinical labs, healthcare givers, academicians, and researchers for best practices to help increase the probability of success in drug development and improve patient management.

Több

Tartalomjegyzék:

1. Pharmaceutical crisis2. Applications of biomarkers for different purposes in drug development 3. Pharmacogenetics of therapeutics4. Precision medicine and companion diagnostics in drug development5. Essential attributes of an acceptable in-vitro diagnostic test6. Fundamentals of Assay Development and Validation7. Essentials of Laboratory Quality Management8. Biological variables and their potential impact on biomarkers and precision medicine initiative9. Pre-analytical Variables and their potential impact on biomarkers and precision medicine initiative10. Analytical Discrepancies and their potential impact on biomarkers and precision medicine initiative11. Road Map to Best Practices